ERBB2 and cancer: Sample sizes were small for lymphovascular invasion on core biopsy (7), inflammatory cancer (13), symptoms of possible metastatic disease (23), previous contralateral (36) or ipsilateral cancer (41), T3 disease (44), and ER-negative, HER2-positive disease (46).